Table 3.ÿList of genes showing lower expression in tumors with 1pLOH

Table 2. List of genes showing higher expression in tumors with 1pLOH

Table 2. Partially Down-Regulated Genes in Patients with CML

Table 3. Partially Up-Regulated Genes in Patients with CML

Table 3 Distribution of overexpressed and underexpressed genes mapping to chromosomes 3 and 8. Shown are the gene name  symbol  chromosomal location  and expression level results of the gene from the 1.7K3 microarray expression analysis of serous type tum

Table 2. Use of Gene Expression Profiles to Predict Outcome for Patients with Diffuse Large B-Cell Lymphoma

Supplemental Table 2:ÿFunctional groupings of representative genes with altered gene expression (at least 3-fold change in 3 or more cases) during FCL higher-grade transformation.

Table I. Differentially expressed genes in androgen-sensitive (LNCaP-C33) and androgen-independent (LNCaP-C81) cells of LNCaP cell model identified by microarray analysis

Table 2. Genes Showing Different Expression Between CR (Complete Response) and NC (No Change) Groups; B. Genes Showing Relatively Higher Expression in Radioresistant Carcinoma Cells than in Radiosensitive Cells 
Category

Table 12b. Genes selected by CFS: E2A-PBX1

Table 12f. Genes selected by CFS (chosen so that they have high correlation with the corresponding class and low correlation with each other): T-ALL

Table 12g. Genes selected by CFS: TEL-AML1

Table 12e. Genes selected by CFS (chosen so that they have high correlation with the corresponding class and low correlation with each other): Novel

Table 11a. Genes selected by Chi-square: BCR-ABL

Table 11b. Genes selected by Chi-square: Novel

Table 11c. Genes selected by Chi-square: T-ALL

Table 11d. Genes selected by Chi-square: TEL-AML1

Table 12a. Genes selected by CFS: BCR-ABL

Table 12d. Genes selected by CFS (chosen so that they have high correlation with the corresponding class and low correlation with each other): MLL

Table 12c. Genes selected by CFS: Hyperdiploid >50

Fig. 3. Molecular profiles of all 61 tumors as defined by the 110 nonredundant genes whose expression statistically significantly differentiates BRCA1 and BRCA2 tumors (P<.0001).